Feb 12, 2018
Loma Linda, California, United States
A new, innovative deep brain stimulation (DBS) system, called Vercise, was successfully implanted in an 81-year-old patient with Parkinson’s Disease at Loma Linda University Health, the first such procedure in Southern California and the fourth in the nation to utilize the DBS device to treat Parkinson’s.
The procedure involves the implant of a thin wire — called a lead — into the patient’s targeted brain region. In this particular case, the patient received electrodes on each side of the brain, including the battery. Electrical stimulation is delivered via the lead, which helps control abnormal brain activity that causes tremors, stiffness or slow movement.
“This device opens more doors for Parkinson’s patients in need of deep brain stimulation,” Lopez-Gonzalez said. “With time, we will be able to monitor the device’s progress and hopefully determine if this is more beneficial.”
In December 2017, the FDA approved the Boston Scientific device, the third approved device in the United States for performing DBS.
The rechargeable device was first approved in Europe following various clinical trials. It has been used to increase precision and avoid common side effects of DBS therapy that affects the brain beyond the intended target. It offers a multi-source constant current, allowing flexible control of stimulation that adapts to individual physiologies, impedance variabilities, and disease progression.